Array BioPharma cancer drug succeeds in late-stage study

December 16, 2015 12:18 PM

29 0

Array BioPharma Inc said its experimental drug helped patients with a form of melanoma live longer without their cancer progressing, in an ongoing late-stage study.

The company's stock jumped about 24 percent before the opening bell on Wednesday.

Also read: U.S. FDA approves AstraZeneca's immunotherapy for lung cancer

Read more

To category page